$MMSI News
Last published 6d ago
- 6d agoMMSIMerit Medical Presents Real-World Data from the AVF Cohort of the WRAP Global RegistryGlobeNewswireThe 6-month target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 for patients in the arteriovenous fistula (AVF) cohort were 92.7% and 76.7%, respectivelyThe real-world patency results
- 1w agoMMSIMERIT MEDICAL SYSTEMS INC - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 7.01 Item 9.01
- 1w agoMMSIMerit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 GuidanceGlobeNewswireFinancial Highlights† Reported revenue of $416.2 million, up 8.4%Constant currency revenue* and constant currency revenue, organic* up 8% and up 9%, respectivelyGAAP operating margin of 14.1%, compared to 11.1% in
- 1w agoMMSIMerit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing TechnologyGlobeNewswireSOUTH JORDAN, Utah, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in
- 1mo agoMMSIMerit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026GlobeNewswireSOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter
- 2mo agoMMSIMerit Medical to Participate in Upcoming Investors Conferences in SeptemberGlobeNewswireSOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following
- 2mo agoMMSIMerit Medical Announces Global Operations Leadership TransitionGlobeNewswireSOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to join Merit as
- 3mo agoMMSI2026 SMID CAP EXECUTIVE INSIGHTS EVENT (VIRTUAL) - MERIT MEDICAL SYSTEMS INCEarnings Call TranscriptsHi, everyone. Thanks for joining. I'm Jill Hall, Head of Small and Mid-Cap Strategy and B of A Global Research. So, welcome to first session of day two of our virtual Mid-Cap event. Happy you could join us. If you need t
- 3mo agoMMSICG 46TH ANNUAL GROWTH CONFERENCE - MERIT MEDICAL SYSTEMS INCEarnings Call TranscriptsWell thank you for everyone for joining I'm John Young I'm one of Canaccord's MedTech analysts and we're thrilled to host Merit Medical. With us today is CFO Rahul Parra and Travis McDougal, Executive VP of Corporate Fin
- 3mo agoMMSIMerit Medical to Participate in Upcoming Investors Conferences in AugustGlobeNewswireSOUTH JORDAN, Utah, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader in healthcare technology, today announced that management will participate in the upcoming investor
- 3mo agoMMSIMMSI Q2 2026 Earnings Call - MERIT MEDICAL SYSTEMS INCEarnings Call TranscriptsThis video tutorial shows how to install Kali Linux 2017.1 LXDE on VMware Workstation or VMware Workspace. Kali LXD is a very simple and easy-to-use software that can be installed on your computer. To install it, click o
- 3mo agoMMSIMMSI Q2 2026 Earnings Call - MERIT MEDICAL SYSTEMS INCEarnings Call TranscriptsThis video tutorial shows how to install Kali Linux 2017.1 LXDE on VMware Workstation or VMware Workspace. Kali LXD is a very simple and easy-to-use software that can be installed on your computer. To install it, click o
- 3mo agoMMSIMerit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 GuidanceGlobeNewswireFinancial Highlights† Reported revenue of $418.8 million, up 10%Constant currency revenue* and constant currency revenue, organic* up 9% and up 9%, respectivelyGAAP operating margin of 14.4%, compared to 12.3% in prior
- 4mo agoMMSIMerit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026GlobeNewswireSOUTH JORDAN, Utah, July 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter
- 5mo agoMMSIMerit Medical Shareholders Elect Scott R. Ward to Board of DirectorsGlobeNewswireSOUTH JORDAN, Utah, May 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that shareholders elected Scott R.
- 6mo agoMMSIMerit Medical to Participate in the Bank of America Healthcare ConferenceGlobeNewswireSOUTH JORDAN, Utah, May 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that Merit management will
- 6mo agoMMSIMerit Medical Reports First Quarter 2026 Results and Updates Full-Year GuidanceGlobeNewswireFinancial Highlights† Reported revenue of $381.9 million, up 7%Constant currency revenue* and constant currency revenue, organic* up 5% and up 3%, respectively Constant currency revenue, organic*
- 7mo agoMMSIMerit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026GlobeNewswireSOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter
- 7mo agoMMSIMerit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology PortfolioGlobeNewswireSOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through
- 7mo agoMMSIMedtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back painPR NewswireMedtronic plc, a global leader in healthcare technology, today announced that it has entered into a distribution agreement with Merit Medical...
- 8mo agoMMSIMerit Medical Launches the Resilience Through-the-Scope Esophageal StentGlobeNewswireSOUTH JORDAN, Utah, March 16, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced the US commercial release of the Resilience Through-the-Scope
- 8mo agoMMSIMerit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 GuidanceGlobeNewswireFourth Quarter Highlights† Reported revenue of $393.9 million, up 11%Constant currency revenue* and constant currency revenue, organic* up 10% and up 7%, respectivelyGAAP operating margin of 13.8%, compared to
- 10mo agoMMSIMerit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025GlobeNewswireSOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann
- 10mo agoMMSIMerit Medical to Participate at the J.P. Morgan Healthcare ConferenceGlobeNewswireSOUTH JORDAN, Utah, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader in healthcare technology, today announced that management will participate in the 44th Annual J.P. Morgan
- 11mo agoMMSIMerit Medical Systems, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 12mo agoMMSIMerit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable EndoprosthesisGlobeNewswireSOUTH JORDAN, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced today that the U.S. Centers for Medicare & Medicaid Services
- 1y agoMMSIMerit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) TrialGlobeNewswireThe target lesion primary patency (TLPP)1 and access circuit primary patency (ACPP)2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty (PTA) through 24
- 1y agoMMSIMerit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) TrialGlobeNewswireAt 24 months, the target lesion primary patency (TLPP)1 was 41.7%At 24 months, the access circuit primary patency (ACPP)2 was 25.7% SOUTH JORDAN, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc.
- 1y agoMMSIMerit Medical Reports Third Quarter 2025 Results and Updates Full-Year GuidanceGlobeNewswireHighlights† Reported revenue of $384.2 million, up 13.0%Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 7.8%, respectivelyGAAP operating margin of 11.1%, compared to 11.0% in
- 1y agoMMSIMerit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon TechnologyGlobeNewswireAsset acquisition would expand Merit's Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other gastrointestinal disorders. Asset acquisition is projected to add
- 1y agoMMSIPENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase AgreementPR NewswirePENTAX Medical, a division of HOYA Group and a global leader in flexible reusable endoscopy, today announced an asset purchase agreement with Merit...
- 1y agoMMSIMerit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025GlobeNewswireSOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial
- 1y agoMMSIMerit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free TechnologyGlobeNewswireSOUTH JORDAN, Utah, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced a significant milestone for breast cancer treatment:
- 1y agoMMSIMerit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee OsteoarthritisGlobeNewswireSOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced that Embosphere® Microspheres are now indicated in the
- 1y agoMMSIFirst Patient Enrolled in Merit Medical's WRAPSODY (WRAP) North America RegistryGlobeNewswireThe WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE).The first WRAP North America
- 1y agoMMSIMerit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix TechnologyGlobeNewswireSOUTH JORDAN, Utah, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced the US commercial release of the Prelude Wave™
- 1y agoMMSIMerit Medical Systems, Inc. (MMSI) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoMMSIMerit Medical Reports Second Quarter 2025 Results and Updates Full-Year GuidanceGlobeNewswireHighlights† Reported revenue of $382.5 million, up 13.2%Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 6.7%, respectivelyGAAP operating margin of 12.3%, compared to 13.6% in
- 1y agoMMSIMerit Medical Names Martha Aronson as New President and Chief Executive OfficerGlobeNewswireFred Lampropoulos will continue to serve as Chairman of Merit's Board of Directors Merit announces preliminary unaudited revenue for the quarter ended June 30, 2025 SOUTH JORDAN, Utah, July 07, 2025 (GLOBE NEWSWIRE)
- 1y agoMMSIMerit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025GlobeNewswireSOUTH JORDAN, Utah, July 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial
- 1y agoMMSIMerit Medical Acquires Biolife Delaware, L.L.C.GlobeNewswireAcquired business offers the StatSeal® and WoundSeal® products, which provide hemostasis solutions that complement the wide range of procedures Merit's portfolio supports.Acquisition projected to add
- 1y agoMMSIMerit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable EndoprosthesisGlobeNewswireThe WRAPSODY CIE is designed to help physicians prolong functional vascular access in hemodialysis patients.Approval was supported by superior 12-month target lesion primary patency (70.1%) and access circuit primary
- 1y agoMMSIMerit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) TrialGlobeNewswireSOUTH JORDAN, Utah, May 05, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced that the 12-month results from the single-arm cohort of the WAVE trial
- 1y agoMMSIMerit Medical Reports First Quarter 2025 Results and Updates Full-Year GuidanceGlobeNewswireFirst Quarter Highlights† Reported revenue of $355.4 million, up 9.8%Constant currency revenue* and constant currency revenue, organic* up 10.9% and up 6.0%, respectivelyGAAP operating margin of 11.5%,
- 1y agoMMSIMerit Medical Launches the Ventrax™ Delivery SystemGlobeNewswireSOUTH JORDAN, Utah, April 09, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader in healthcare technology, today announced the US commercial release of its Ventrax Delivery System. The
- 1y agoMMSIMerit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025GlobeNewswireSOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial
- 1y agoMMSIUpdated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERDGlobeNewswireSOUTH JORDAN, Utah, March 27, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced today that the American Society for Gastrointestinal Endoscopy
- 1y agoMMSIMerit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)GlobeNewswireAt 6 months, the WRAPSODY CIE achieved 89.8% and 72.6% target lesion primary patency and access circuit primary patency, respectively.At 12 months, the WRAPSODY CIE achieved 70.1% and 58.1% target lesion primary patency
- 1y agoMMSIMerit Medical Systems, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 1y agoMMSIMerit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year PartnershipGlobeNewswireSOUTH JORDAN, Utah, March 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced that Chairman and Chief Executive Officer, Fred Lampropoulos, will